From Scleroderma News (SclerodermaNews.com), December 3, 2015:
Case study followed CREST syndrome patient for 21 years
“A new case study revealed that long-term treatment with therapeutic plasma exchange (TPE) led to successful symptom management and disease remission in a patient with CREST syndrome, or limited systemic scleroderma. The study, recently presented at the AABB Annual Meeting in California, is entitled “Benefit of Long-Term Therapeutic Plasma Exchange Treatment in a Patient with CREST Syndrome (Limited Systemic Scleroderma): A 21-Year Success Story,” and its abstract was published in the journal Transfusion.”
See the full news story for details: http://sclerodermanews.com/2015/12/03/scleroderma-patient-long-term-remission-tpe-treatment/.
For more information on this case study, contact the Corresponding Author at firstname.lastname@example.org.